Medical Director, GoodLife Fitness Chair and Senior Scientist University Health Network University of Toronto Toronto, Ontario, Canada
a. ASCVD risk assessment with a “sex and gender” lens- Emerging importance of a personalized approach b. Exercise in my high risk and ASCVD patient-what does it prevent? c. My diabetic patient with and without ASCVD i. 1st line-Forget metformin, start SGLT2i? ii. Avoiding therapeutic inertia-The cardiologist should initiate treatment in 2022
